Furthermore CD19−/− mice showed reduced fibrosis and improved survival compared to WT mice, suggesting a potential harmful role for B cells in the development of pulmonary fibrosis upon BLM treatment [238]. This evidence concerns the gene CD19 and pulmonary fibrosis.